EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Nanobodies in the fight against infectious diseases: repurposing nature's tiny weapons

Soha S Rizk, Dina M Moustafa, Shahira A ElBanna, Hanzada T Nour El-Din, Ahmed S Attia

World Journal of Microbiology and Biotechnology · 2024

DOI: 10.1007/s11274-024-03990-4 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift World Journal of Microbiology and Biotechnology, 2024. Verfasst von Soha S Rizk und 4 weiteren Autor:innen. Beteiligte Einrichtung: Microbiology and Immunology Postgraduate Program, Faculty of Pharmacy, Cairo University, Cairo, 11562, Egypt. Hauptthemen laut MEDLINE: Single-Domain Antibodies, Communicable Diseases. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 190 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Academy of Scientific Research and Technology (ASRT), Egypt, Cairo University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nanobodies are the smallest known antigen-binding molecules to date. Their small size, good tissue penetration, high stability and solubility, ease of expression, refolding ability, and negligible immunogenicity in the human body have granted them excellence over conventional antibodies. Those exceptional attributes of nanobodies make them promising candidates for various applications in biotechnology, medicine, protein engineering, structural biology, food, and agriculture. This review presents an overview of their structure, development methods, advantages, possible challenges, and applications with special emphasis on infectious diseases-related ones. A showcase of how nanobodies can be harnessed for applications including neutralization of viruses and combating antibiotic-resistant bacteria is detailed. Overall, the impact of nanobodies in vaccine design, rapid diagnostics, and targeted therapies, besides exploring their role in deciphering microbial structures and virulence mechanisms are highlighted. Indeed, nanobodies are reshaping the future of infectious disease prevention and treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Single-Domain AntibodiesCommunicable DiseasesHumansAnimalsBiotechnologyProtein Engineering

Stichwörter der Autor:innen

BacteriaDiagnosisInfectious diseasesNanobodiesProphylaxisTreatmentViruses

Substanzen

Single-Domain Antibodies

Autor:innen und Institutionen

  • Microbiology and Immunology Postgraduate Program, Faculty of Pharmacy, Cairo University, Cairo, 11562, Egypt.
  • Department of Medical Sciences, Faculty of Dentistry, The British University in Egypt, El Sherouk City, Cairo, 11837, Egypt.
  • Department of Microbiology and Immunology, Faculty of Pharmacy, Cairo University, Cairo, 11562, Egypt.
  • Department of Microbiology and Immunology, Faculty of Pharmacy, Cairo University, Cairo, 11562, Egypt. ahmed.attia@pharma.cu.edu.eg.

Förderung

  • Academy of Scientific Research and Technology (ASRT), Egypt
  • Cairo University

Zitieren

APA

Rizk, S. S., Moustafa, D. M., ElBanna, S. A., Nour El-Din, H. T., & Attia, A. S. (2024). Nanobodies in the fight against infectious diseases: repurposing nature's tiny weapons. World Journal of Microbiology and Biotechnology. https://doi.org/10.1007/s11274-024-03990-4

Vancouver

Rizk SS, Moustafa DM, ElBanna SA, Nour El-Din HT, Attia AS. Nanobodies in the fight against infectious diseases: repurposing nature's tiny weapons. World Journal of Microbiology and Biotechnology. 2024. doi:10.1007/s11274-024-03990-4

BibTeX
@article{Rizk2024,
  author = {Rizk, Soha S and Moustafa, Dina M and ElBanna, Shahira A and Nour El-Din, Hanzada T and Attia, Ahmed S},
  title = {Nanobodies in the fight against infectious diseases: repurposing nature's tiny weapons},
  journal = {World Journal of Microbiology and Biotechnology},
  year = {2024},
  doi = {10.1007/s11274-024-03990-4}
}
Kostenlos starten →